
Company valuation, historical trends, and peer comparisons.
According to Nanobiotix S.A.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.29B. This represents a change of 77.68% compared to the average of 723.56M of the last 4 quarters.
The mean historical Enterprise Value of Nanobiotix S.A. over the last ten years is 279.55M. The current 1.29B Enterprise Value has changed 359.90% with respect to the historical average. Over the past ten years (40 quarters), NBTX's Enterprise Value was at its highest in in the June 2026 quarter at 1.56B. The Enterprise Value was at its lowest in in the January 2011 quarter at 0.
Average
279.55M
Median
217.68M
Minimum
140.76M
Maximum
967.22M
Discovering the peaks and valleys of Nanobiotix S.A. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 572.12%
Maximum Annual Enterprise Value = 967.22M
Minimum Annual Increase = -34.84%
Minimum Annual Enterprise Value = 140.76M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 967.22M | 572.12% |
| 2024 | 143.91M | -34.40% |
| 2023 | 219.36M | 55.85% |
| 2022 | 140.76M | -34.84% |
| 2021 | 216.00M | -18.90% |
| 2020 | 266.35M | 41.27% |
| 2019 | 188.54M | -11.36% |
| 2018 | 212.70M | -3.39% |
| 2017 | 220.17M | -0.15% |
| 2016 | 220.50M | 4.02% |
The current Enterprise Value of Nanobiotix S.A. (NBTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
443.50M
5-year avg
337.45M
10-year avg
279.55M
Nanobiotix S.A.’s Enterprise Value is greater than Immix Biopharma, Inc. (377.39M), greater than Puma Biotechnology, Inc. (493.77M), less than ImmunityBio, Inc. (9.16B), greater than Tyra Biosciences, Inc. (1.20B), greater than ArriVent BioPharma, Inc. (503.93M), greater than Nuvectis Pharma, Inc. (603.95M), greater than Syndax Pharmaceuticals, Inc. (618.71M), greater than Black Diamond Therapeutics, Inc. (98.05M), greater than Candel Therapeutics, Inc. (469.28M), greater than Kura Oncology, Inc. (825.14M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 377.39M | $601.88M | |
| 493.77M | $525.49M | |
| 9.16B | $8.43B | |
| 1.20B | $1.27B | |
| 503.93M | $658.26M | |
| 603.95M | $626.11M | |
| 618.71M | $1.17B | |
| 98.05M | $100.28M | |
| 469.28M | $621.33M | |
| 825.14M | $870.92M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nanobiotix S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Nanobiotix S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Nanobiotix S.A.'s Enterprise Value?
What is the highest Enterprise Value for Nanobiotix S.A. (NBTX)?
What is the 3-year average Enterprise Value for Nanobiotix S.A. (NBTX)?
What is the 5-year average Enterprise Value for Nanobiotix S.A. (NBTX)?
How does the current Enterprise Value for Nanobiotix S.A. (NBTX) compare to its historical average?